About Us

Tomowave builds genuine long-term partnerships with clients based on a powerful collaborative culture that is completely results-driven.

Precision Imaging

Revolutionizing Healthcare

TomoWave develops proprietary optoacoustic tomography and laser ultrasound systems for combined functional/molecular and anatomical imaging with applications in detection of cancer and image-guided interventions

About Us

TomoWave Laboratories is a research and development company with broad experience and expertise in the development of innovative technologies for optoacoustic tomography (OAT), imaging, sensing and monitoring in biomedical applications. We consist of a strong team of inspired individuals who are on a mission to produce innovative biomedical solutions. With recent developments and recognition, TomoWave Laboratories introduced its subsidiary, TomoWave Systems, consisting of a strong team of engineers and sales experts to bring our innovations to you!

Our Motto

To contribute to human welfare through leading optoacoustic research and developing solutions that advance medicine and the biomedical sciences.

To maintain a welcoming, supportive, and collaborative workplace where our employees receive great satisfaction in their work.

To produce novel and cost-effective imaging, sensing, and monitoring products based on the principles of optoacoustics.

Our Story

In 1880, Alexander G. Bell heard “a pure musical tune” in a a closed gas volume that has absorbed a modulated sunlight beam. However, it was decades later that the physicists had employed this discovery in medical applications. It wasn’t until the early 20th century that the photoacoustic/optoacoustic effecthad become a sensitive technology for detection of malignant tumors. Int he beginning of the 20th century, when the first highly sensitive microphones were first designed, spectroscopy experts began to utilize the photoacoustic effect for the characterize of molecular content in gas mixtures. In 1964, shortly after the discovery of lasers, intense pulses of light were employed to enhance dramatically the effectiveness of photoacoustic generation.

Since then, a number of applications in nondestructive evaluation and spectroscopic characterization of solid and liquid materials have been found for the photoacoustic effect.  In early 1980-s Alan Rosencwaig, Theodore Bowen, Myron Wolbarsht and other researchers independently proposed the use of laser photoacoustic effect for various medical diagnostic procedures.  However, only the 1990s brought about technological breakthroughs that allowed our TomoWave Labs founder, Dr. Alexander Oraevsky, to initiate work on designing a novel technology for biomedical visualization combining the advantages of optical and acoustic imaging. Immediately, several groups followed this direction.  In the beginning of the 21st century the necessary critical mass of resources (human and financial) has been achieved and optoacoustic imaging (also called photoacoustic imaging) has become one of the fastest growing technologies in the area of biomedical imaging.

In a short period of time, since the establishment of our company in 2011, TomoWave has come a long way in developing efficient OAT systems through optical and acoustic modifications. Our systems include Optoacoustic Imaging Systems for preclinical and clinical research purposes. Many of our components are fully customizable to your specifications and medical imaging needs. We are also able to provide certain system components such electronics, imaging modules as well as PTFE tubing for your research needs. Please contact us for further information regarding.

Read More Collapse

Management

Alexander A Oraevsky, PhD

Chief Executive Officer and Chief Technology Officer

Alexander C. Wallstein, MEE, MBA

Acting Chief Operating Officer

Alexander C. Wallstein, MEE, MBA

Acting Chief Financial Officer

Aleksey N. Krylov, CFA

Director of Business Development

Request a Free Demo

See how Tomowave can elevatre your imaging.

Technologies

Optoacoustic Tomography
Laser Ultrasound Imaging
Optoacoustic Temperature Imaging

Products

Lois-3d
Maestro
Symphony

Alexander A Oraevsky, PhD

Chief Executive Officer and Chief Technology Officer

Dr. Alexander A. Oraevsky has 25+ years of experience managing research and development laboratories in academia and small businesses. Alexander obtained a doctorate in laser spectroscopy and laser biophysics from the USSR Academy of Sciences. He began his pioneering research in the field of optoacoustic imaging, sensing and monitoring in 1988 and presently referred as the Father of biomedical optoacoustic imaging. Prior to foundation of TomoWave Laboratories in 2010, he served as Chief Scientific Officer and Board Member of Seno Medical Instruments (San Antonio, Texas), Vice-President of Research and Development for Fairway Medical Technologies (Houston, Texas). In his academic career he held Professor and other honorary faculty positions at the University of Texas Medical Branch in Galveston, Rice University (Houston, Texas), the University Carlos III of Madrid, Guangzhou Medical University and the University of Houston. Dr. Oraevsky is the recipient of multiple research awards advancing biomedical applications of the optoacoustic imaging sensing and monitoring, including international Berthold Leibinger Innovations Prize 2014. Alexander is the primary inventor of 21 patents. In 1999 he founded a conference dedicated to biomedical optoacoustics under auspices of SPIE Photonics West Symposium, presently titled “Photons plus Ultrasound: Imaging ad Sensing. This conference enabled rapid global spread and exponential growth of the optoacoustic imaging technologies.

Alexander C. Wallstein, MEE, MBA

Acting Chief Operating Officer

Alexander has a unique mix of engineering, product development, strategy and life-sciences in his resume. His real passion is innovation to fill an unmet need and that is why he is excited about the prospects of optoacoustic imaging in cancer diagnostics and image guided interventions. Prior to joining TomoWave, Alexander was the COO of DIH, the global leader in neuro-rehabilitation robotics. He prepared the company for IPO and focused the 400 employee organization on customer value and sustainable growth. Before that, he was a vice president at Medtronic including 2.5 years based in China leading Commercial Operations. He also worked at Johnson & Johnson (Biosense Webster, cardiac ablation) in strategic portfolio planning (R&D roadmap) and Danaher in their dental platform in business development (M&A). He also spent 5 years at McKinsey&Company as consulting team leader in aerospace, automotive and life-sciences.

Aleksey N. Krylov, CFA,

Acting Chief Financial Officer

Aleksey is an experienced finance, business development and operating executive with a background in venture capital raising, M&A and corporate development. Prior to his transition to CFO role, he served as an Interim Chief Financial Officer of DIH International, Ltd., a Swiss-Chinese medical equipment manufacturer with $80m in sales and 400 employees globally Aleksey led the reverse merger of private SELLAS Life Sciences into a publicly listed target. He also consulted with CHR Capital as an investment analyst with a focus on mergers and acquisitions, capital raising, private equity investment and restructuring transactions. Since about 2009, he also provided consulting services through FTERA Advisors to early-stage and small-cap companies in various industries including life sciences, medical technologies and healthcare IT.

Jim Wu, MD, MBA

Director of Business Development

Mr. Wu has been involved in the investment, healthcare, and international trade industries for over 25 years. He has extensive experience in international trade import and export, procurement and outsourcing, international business development, expanding product markets, establishing distribution networks, and international business cultural consulting. He is the founder and CEO of the HealthTech investment company SaniMed Science Group. He is an outstanding alumnus and alumni advisor of the Peking University Health Science Center, and a member of the leadership committee of the Joint Institute for Translational and Clinical Research between Peking University Health Science Center and the University of Michigan Medical School. Mr. Wu has been selected as a core member of the ‘Health Tech’ founders at The Founder Institute, which spans over 200 cities worldwide and includes more than 6,800 alumni enterprises across six continents. He is also a member of the American physician entrepreneurship organization, InnovatorMD. Mr. Wu graduated from the Peking University Health Science Center in 1994 with a Bachelor of Medicine degree in clinical medicine, and in 2005 he graduated from the Bauer College of Business at the University of Houston in the USA with a Master of Business Administration degree.

Kim Tillinghast

CPFA™, Principal, Partner

Kim Tillinghast began her career in the banking industry in 1985. She graduated with a degree in Finance from West Texas State University in 1990 and has continued her education by earning her Series 24 General Securities Principal Exam and Certified Plan Fiduciary Advisor (CPFA™). Shortly thereafter she started her brokerage career at a traditional wirehouse in downtown Los Angeles, California in 1991. After relocating to Orange County, Kim became an independent financial advisor in May of 1993. She brings over 37 years in the banking and finance industry with experience ranging from designing, developing, employing and maintaining complex investment strategies, Pension Plans, Employee Stock Option Plans, Corporate Finance, Estate Planning and Transition. Outside of her career, she served as Co-Chair of the Dallas County Susan G. Komen Race for the Cure 2013 and 2014 and currently serves on the Board of the Tillinghast Society, Inc. With a deep love for animals, she continues to volunteer for multiple emergency animal response teams including Red Rover, HSUS, UAN, ASPCA and volunteers weekly at the Irving Animal Shelter. Kim also loves worldwide adventure travel and has many amazing experiences visiting almost half of the world’s countries and all seven continents, twice.

Karthik Muraliraj

CFP®, ChFC®, CLU®, RMA®, Partner

Karthik Muraliraj was raised in Fort Worth, Texas, and developed an interest in investing and economics at a young age. After graduating from the University of Texas at Austin with a Bachelor of Arts in Economics and a minor in Business, he started his career as a financial professional in 2008. Throughout his career, Karthik has continued to educate himself by gaining multiple designations. Since moving to Dallas, he has been an active member in the community—volunteering with organizations such as the network of Indian Professionals, Dallas Autumn Ball and Reading Partners. Karthik is an avid sports fan and enjoys supporting his alma mater as a proud member of the Texas Exes Dallas Chapter. In his free time, Karthik enjoys cooking, travel, fitness and spending time with this wife, son, dog, and cat.

Crystal Arredondo

MBA, CDFA®, CPFA™, Partner

Crystal Arredondo was born and raised in Germany. She moved to Texas following her parents’ decision to retire after serving an overseas career in the Armed Forces. Seeing firsthand the difficult transition to civilian life after retirement, Crystal obtained her MBA in Finance at the University of North Texas and began her career as a financial advisor. In 2009, she completed the Retirement Planning Specialist Program at the Wharton School of Business, University of Pennsylvania. In 2018, she earned her designation of Certified Divorce Financial Analyst® (CDFA®). In 2022, she earned the additional designation as a Certified Plan Fiduciary Advisor (CPFA™). As the daughter of an immigrant mother, she especially enjoys helping women and business owners make decisions that affect their financial independence. She served as the 2015-16 Chair for the National Association of Women Business Owners (NAWBO) and 2016-17 Chair for the NAWBO Institute of Entrepreneurial Development.

Philip Strunk

CFP®, CPA, Partner

Philip Strunk is a native of Houston, TX. Philip earned his Bachelor of Business Administration and Masters in Professional Accounting from the University of Texas at Austin’s McCombs School of Business. He earned his designation as Certified Public Accountant (CPA) in 2004 and CERTIFIED FINANCIAL PLANNER (TM) certification in 2010. Having started his career with Deloitte & Touche, LLP in 2005, Philip spent a year and a half in Deloitte’s Audit and Assurance Services group and provided a variety of financial services for a number of Fortune 500 companies. He decided in late 2006 that his talent and passion for investments were best suited for working with smaller groups and individuals. After obtaining the required securities registrations and insurance licenses, Philip became a financial advisor. The impact was plainly visible and more fulfilling. Philip serves as the Investment Director for MPACT.

John C. Farris

CAP®, CFS®, Partner

John C. Farris is a founding partner and has more than forty years in both public and private business serving in a variety of management and leadership capacities. John completed the Retirement Planning Specialist Program at the Wharton School of Business at the University of Pennsylvania earning the Retirement Planning Specialist designation. John and his family have a history of philanthropic giving through numerous non-profit organizations. John recently completed his designation as a Chartered Advisor in Philanthropy® (CAP®). He is also a member of The International Association of Advisors in Philanthropy. His primary goal is to help people give intelligently with love and thereby experience the true joy of helping others. John lives in Park Cities and has served on the Public Works Advisory Council, as finance director of the BSA West Park District, the BSA Troop 82 Executive Board, and as a BSA Assistant Scoutmaster for Troop 82, Dallas, Texas.